| Issue | Title | |
| Vol 1, No 1 (2017): ARxCH Issue 1 | Agricultural Antibiotics and Their Impact on Human Health | Abstract PDF |
| Edwin Ruppert | ||
| Vol 1, No 1 (2017): ARxCH Issue 1 | ARxCH | Abstract PDF |
| Jason W Guy | ||
| Vol 2, No 1 (2018): ARxCH | ARxCH Final Print Version | Abstract PDF |
| ARxCH Organization | ||
| Vol 3, No 1 (2019): ARxCH | Benefits and Risk of Aspirin as Primary Prevention of Cardiovascular Disease | Abstract PDF |
| Grant Morgan & Thomas Brown | ||
| Vol 3, No 1 (2019): ARxCH | Breakthrough Therapy Designation Awarded to Crizanlizumab, a New Treatment Option for Sickle Cell Disease | Abstract PDF |
| Cassandra Kuhn & Olivia Reiber | ||
| Vol 2, No 1 (2018): ARxCH | Calcitonin Gene-Related Peptide Receptors and the Prevention of Migraines | Abstract PDF |
| Brian Schuler | ||
| Vol 1, No 1 (2017): ARxCH Issue 1 | CE: Entresto: An Overview for Pharmacists | Abstract PDF |
| David Comshaw | ||
| Vol 2, No 1 (2018): ARxCH | CE: New Insulin/GLP-1RA Agents: Overview for the Pharmacist | Abstract PDF |
| Alysa Martin | ||
| Vol 2, No 1 (2018): ARxCH | CE: Overview of the Gestational Diabetes Educational Gap | Abstract PDF |
| Erica Hagen, Shiader Thao | ||
| Vol 1, No 1 (2017): ARxCH Issue 1 | CE: Review of Human Immunodeficiency Virus and Updated Guidelines | Abstract PDF |
| Erica Hagen | ||
| Vol 2, No 1 (2018): ARxCH | CE: Sodium-Glucose Co-transporter 2 Inhibitors: Safety Considerations and Clinical Implications for Healthcare Providers | Abstract PDF |
| Gyen Musgrave | ||
| Vol 1, No 1 (2017): ARxCH Issue 1 | CE: Summary of 2016 CHEST Guidelines | Abstract PDF |
| Emily Doycich | ||
| Vol 3, No 1 (2019): ARxCH | Ceiling dose of Ketorolac in Treatment of Moderate to Severe Acute Pain in an Emergency Department Setting | Abstract PDF |
| Nicole Babiak | ||
| Vol 1, No 1 (2017): ARxCH Issue 1 | DOAC Reversal Agents | Abstract PDF |
| Gyen Musgrave | ||
| Vol 3, No 1 (2019): ARxCH | Electronic Cigarettes: Ongoing Research | Abstract PDF |
| Elizabeth Claus & Vivian Lee | ||
| Vol 3, No 1 (2019): ARxCH | GOLD 2018 Report: A Review | Abstract PDF |
| Jonathan Mitchell | ||
| Vol 3, No 1 (2019): ARxCH | Overview of Selected Novel Drugs Approved in 2018 | Abstract PDF |
| Madison Donnelly & Shawn Hodge | ||
| Vol 2, No 1 (2018): ARxCH | Review of Alzheimer’s Disease Treatment and Potential Future Therapies | Abstract PDF |
| Ralf Jadoopat | ||
| Vol 1, No 1 (2017): ARxCH Issue 1 | Review of Iron-Overdose in Pediatric Patients | Abstract PDF |
| Emily Doycich | ||
| Vol 1, No 1 (2017): ARxCH Issue 1 | Review of Parkinson’s Disease Treatment and Future Therapies | Abstract PDF |
| Eric Manning | ||
| Vol 3, No 1 (2019): ARxCH | The ARxCH Print Edition 2019 | Abstract PDF |
| Grant Morgan | ||
| Vol 1, No 1 (2017): ARxCH Issue 1 | The Rising Incidence of C. difficile and Bezlotoxumab: The Targeting of Toxin B | Abstract PDF |
| Brian Schuler | ||
| Vol 3, No 1 (2019): ARxCH | The Watchman Device: An Alternative Treatment in Atrial Fibrillation | Abstract PDF |
| Anastasia Palmer, Ahmed Mohamed, & Shiader Thao | ||
| 1 - 23 of 23 Items | ||